Related Experiment Video
Updated: Dec 3, 2025

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry
Published on: November 21, 2025
Histone lysine demethylases and their functions in cancer
Jayden Sterling1, Sharleen V Menezes1, Ramzi H Abbassi1
1School of Medical Sciences and Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Abstract:
Histone lysine demethylases (KDMs) are enzymes that remove the methylation marks on lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene transcription during both development and malignant transformation. Depending on which lysine residue is targeted, the effect of a given KDM on gene transcription can be either activating or repressing, and KDMs can regulate the expression of both oncogenes and tumour suppressors. Thus, the functions of KDMs can be regarded as both oncogenic and tumour suppressive, contingent on cell context and the enzyme isoform. Finally, KDMs also demethylate nonhistone proteins and have a variety of demethylase-independent functions. These epigenetic and other mechanisms that KDMs control make them important regulators of malignant tumours. Here, we present an overview of eight KDM subfamilies, their most-studied lysine targets and selected recent data on their roles in cancer stem cells, tumour aggressiveness and drug tolerance.
Insights
Histone lysine demethylases (KDMs) regulate gene expression and cancer development. This review covers eight KDM subfamilies, their targets, and roles in cancer stem cells, aggressiveness, and drug tolerance.
Area of Science:
- Epigenetics
- Molecular Biology
- Oncology
Background:
- Histone lysine demethylases (KDMs) are crucial enzymes that remove methylation marks from histone tails.
- These epigenetic modifications regulate gene transcription, impacting development and cancer.
- KDMs can act as oncogenes or tumor suppressors, depending on the specific enzyme and cellular context.
Purpose of the Study:
- To provide an overview of eight KDM subfamilies.
- To highlight their key lysine targets.
- To present recent findings on their roles in cancer stem cells, tumor aggressiveness, and drug tolerance.
Main Methods:
- Literature review of KDM functions.
- Analysis of KDM roles in cancer biology.
- Focus on KDM subfamilies, targets, and cancer-related functions.
Main Results:
- KDMs exhibit context-dependent oncogenic or tumor-suppressive functions.
- They regulate gene transcription through histone and non-histone protein demethylation.
- Recent data link KDMs to cancer stem cell properties, tumor aggressiveness, and drug resistance.
Conclusions:
- KDMs are significant regulators of malignant tumors through diverse epigenetic mechanisms.
- Understanding KDM functions is vital for cancer research and therapeutic strategies.
- Further investigation into KDM roles in cancer stemness and drug tolerance is warranted.
More Related Videos
10:09Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
07:20Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy
Published on: October 18, 2024
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Spreading of Chromatin Modifications
Writers
The writer...
Histone Variants at the Centromere